FDA Adverse Event
Death
Summary report: N
ENDEAVOR SPRINT RX
MDR report key: 2850438
·
Received November 29, 2012
Report
- Report Number
- 9612164-2012-01714
- Event Type
- Death
- Date Received
- November 29, 2012
- Date of Event
- November 1, 2012
- Report Date
- March 14, 2013
- Manufacturer
- MEDTRONIC IRELAND
- Product Code
- NIQ
- PMA / PMN Number
- P060033
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- BR
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
(B)(4): EVALUATION, RESULTS: INHERENT RISK OF PROCEDURE (DEATH). (B)(4).
Additional Manufacturer Narrative · 1
DATE OF EVENT: DATE YEAR ONLY VALID. (B)(4). EVALUATION CODE, RESULTS: INHERENT RISK OF PROCEDURE (STROKE).
Description of Event or Problem · 1
PATIENT DEATH WAS ASSESSED TO BE A CARDIAC DEATH.
Description of Event or Problem · 1
DURING INDEX PROCEDURE THE PATIENT HAD ONE ENDEAVOR SPRINT RX STENT IMPLANTED IN THE RCA. APPROXIMATELY ONE MONTH POST INDEX PROCEDURE, THE PATIENT HAD A STAGED PROCEDURE WHERE TWO ENDEAVOR SPRINT RX STENTS WERE IMPLANTED IN THE CX. APPROXIMATELY 12 MONTHS POST INDEX PROCEDURE THE PATIENT SUFFERED A STROKE. APPROXIMATELY 15 DAYS LATER, THE PATIENT EXPIRED. DEATH IS REPORTED AS NON-CARDIAC, CAUSE UNKNOWN. IT HAS BEEN ASSESSED THAT THE DEATH WAS NOT RELATED TO THE DEVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ENDEAVOR SPRINT RX | STENT, CORONARY, DRUG-ELUTING | NIQ | MEDTRONIC IRELAND | 0005479133 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 00074 YR | Death| H | ASPIRIN AND CLOPIDOGREL |